pharmacie et médicaments – Prise en charge du Beyfortus

This written question asks about the reimbursement status of the drug Beyfortus in France. It seeks clarification on how the drug will be covered by healthcare systems. This concerns patients, healthcare providers, and pharmaceutical companies involved with Beyfortus. It impacts access to and affordability of this specific medication.